Source:http://linkedlifedata.com/resource/pubmed/id/17182560
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-12-21
|
pubmed:abstractText |
NK cells express both inhibitory and activatory receptors that allow them to recognize target cells through HLA class I Ag expression. KIR3DL1 is a receptor that recognizes the HLA-Bw4 public epitope of HLA-B alleles. We demonstrate that polymorphism within the KIR3DL1 receptor has functional consequences in terms of NK cell recognition of target. Inhibitory alleles of KIR3DL1 differ in their ability to recognize HLA-Bw4 ligand, and a consistent hierarchy of ligand reactivity can be defined. KIR3DS1, which segregates as an allele of KIR3DL1, has a short cytoplasmic tail characteristic of activatory receptors. Because it is very similar to KIR3DL1 in the extracellular domains, it has been assumed that KIR3DS1 will recognize a HLA-Bw4 ligand. In this study, we demonstrate that KIR3DS1 is expressed as a protein at the cell surface of NK cells, where it is recognized by the Z27 Ab. Using this Ab, we found that KIR3DS1 is expressed on a higher percentage of NK cells in KIR3DS1 homozygous compared with heterozygous donors. In contrast to the inhibitory KIR3DL1 allotypes, KIR3DS1 did not recognize HLA-Bw4 on EBV-transformed cell lines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-Bw4 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/KIR3DL1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, KIR,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, KIR3DL1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, KIR3DS1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
178
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
235-41
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17182560-Alleles,
pubmed-meshheading:17182560-Antibodies,
pubmed-meshheading:17182560-B-Lymphocytes,
pubmed-meshheading:17182560-Cell Line, Transformed,
pubmed-meshheading:17182560-Cells, Cultured,
pubmed-meshheading:17182560-HLA-B Antigens,
pubmed-meshheading:17182560-Herpesvirus 4, Human,
pubmed-meshheading:17182560-Humans,
pubmed-meshheading:17182560-Killer Cells, Natural,
pubmed-meshheading:17182560-Polymorphism, Genetic,
pubmed-meshheading:17182560-Receptors, Immunologic,
pubmed-meshheading:17182560-Receptors, KIR,
pubmed-meshheading:17182560-Receptors, KIR3DL1,
pubmed-meshheading:17182560-Receptors, KIR3DS1
|
pubmed:year |
2007
|
pubmed:articleTitle |
Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
|
pubmed:affiliation |
School of Biochemistry and Immunology, Trinity College, Dublin, Ireland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|